TBR1T-box, brain, 1
Autism Reports / Total Reports
23 / 46Rare Variants / Common Variants
68 / 1Aliases
TBR1, TBR-1, TES-56Associated Syndromes
-Chromosome Band
2q24.2Associated Disorders
DD/NDD, ADHD, ID, EPS, ASDRelevance to Autism
A number of mutations in the TBR1 gene have been identified in multiple individuals with ASD as described below. Two de novo loss-of-function variants and two de novo missense variants in TBR1 have been identified in simplex ASD cases (PMIDs 22495309, 23160955, 22495311); these variants were not observed in controls or in external databases. Functional analysis in Deriziotis et al., 2014 demonstrated that these four de novo TBR1 variants disrupt multiple aspects of TBR1 function, including interactions with co-regulators such as CASK and/or FOXP2, cellular localization, and transcriptional regulation (PMID 25232744). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) in De Rubeis et al., 2014 identified TBR1 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). Microdeletions encompassing TBR1 have also been identified in patients with developmental delay/intellectual disability (PMIDs 23112752, 24458984). den Hoed et al., 2018 functionally characterized two previously identified de novo TBR1 missense variants seen in ASD probands (p.Trp271Cys from De Rubeis et al., 2014 and p.Lys389Glu from ORoak et al., 2014) and determined that both variants disrupted multiple aspects of TBR1 function, including cellular localization and interactions with CASK, FOXP1, and FOXP2; the authors of this study also determined that the rare inherited TBR1 missense variant p.Gln418Arg (originally reported in an ASD proband in Deriziotis et al., 2014) disrupted the interaction between TBR1 and BCL11A. Through international data sharing, Nambot et al., 2020 collected data from 25 previously unreported individuals with TBR1 variants and found that autistic features were frequently observed (19/25 individuals), with five individuals receiving a diagnosis of ASD according to DSM-IV and/or ADOS criteria. A two-stage analysis of rare de novo and inherited coding variants in 42,607 ASD cases, including 35,130 new cases from the SPARK cohort, in Zhou et al., 2022 identified TBR1 as a gene reaching exome-wide significance (P < 2.5E-06).
Molecular Function
Probable transcriptional regulator involved in developmental processes that is required for normal brain development.
External Links
SFARI Genomic Platforms
Reports related to TBR1 (46 Reports)
# | Type | Title | Author, Year | Autism Report | Associated Disorders |
---|---|---|---|---|---|
1 | Support | Nuclear translocation and transcription regulation by the membrane-associated guanylate kinase CASK/LIN-2 | Hsueh YP , et al. (2000) | No | - |
2 | Support | - | Wang GS , et al. (2004) | No | - |
3 | Primary | Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations | O'Roak BJ , et al. (2012) | Yes | - |
4 | Support | Patterns and rates of exonic de novo mutations in autism spectrum disorders | Neale BM , et al. (2012) | Yes | - |
5 | Support | Investigation of TBR1 Hemizygosity: Four Individuals with 2q24 Microdeletions | Traylor RN , et al. (2012) | No | Epilepsy, PDD, ADHD, autistic features |
6 | Support | Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders | O'Roak BJ , et al. (2012) | Yes | - |
7 | Recent Recommendation | Tbr1 haploinsufficiency impairs amygdalar axonal projections and results in cognitive abnormality | Huang TN , et al. (2014) | No | - |
8 | Support | TBR1 is the candidate gene for intellectual disability in patients with a 2q24.2 interstitial deletion | Palumbo O , et al. (2014) | No | - |
9 | Support | De novo TBR1 mutations in sporadic autism disrupt protein functions | Deriziotis P , et al. (2014) | Yes | - |
10 | Recent Recommendation | Neuronal excitation upregulates Tbr1, a high-confidence risk gene of autism, mediating Grin2b expression in the adult brain | Chuang HC , et al. (2014) | No | - |
11 | Support | De novo mutations in moderate or severe intellectual disability | Hamdan FF , et al. (2014) | No | Autistic features |
12 | Recent Recommendation | Synaptic, transcriptional and chromatin genes disrupted in autism | De Rubeis S , et al. (2014) | Yes | - |
13 | Support | Recurrent de novo mutations implicate novel genes underlying simplex autism risk | O'Roak BJ , et al. (2014) | Yes | - |
14 | Recent Recommendation | T-Brain-1--A Potential Master Regulator in Autism Spectrum Disorders | Chuang HC , et al. (2015) | No | - |
15 | Recent Recommendation | Low load for disruptive mutations in autism genes and their biased transmission | Iossifov I , et al. (2015) | Yes | - |
16 | Support | Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci | Sanders SJ , et al. (2015) | Yes | - |
17 | Recent Recommendation | TBR1 regulates autism risk genes in the developing neocortex | Notwell JH , et al. (2016) | No | - |
18 | Support | Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability | Lelieveld SH et al. (2016) | No | - |
19 | Positive Association | Microsatellite polymorphisms associated with human behavioural and psychological phenotypes including a gene-environment interaction | Bagshaw AT , et al. (2017) | No | - |
20 | Support | Calcium/calmodulin-dependent serine protein kinase (CASK), a protein implicated in mental retardation and autism-spectrum disorders, interacts with T-Brain-1 (TBR1) to control extinction of associative memory in male mice | Huang TN and Hsueh YP (2017) | No | - |
21 | Support | Genomic diagnosis for children with intellectual disability and/or developmental delay | Bowling KM , et al. (2017) | No | - |
22 | Support | Hotspots of missense mutation identify neurodevelopmental disorder genes and functional domains | Geisheker MR , et al. (2017) | Yes | - |
23 | Support | The TBR1-related autistic-spectrum-disorder phenotype and its clinical spectrum | McDermott JH , et al. (2017) | Yes | - |
24 | Recent recommendation | Functional characterization of TBR1 variants in neurodevelopmental disorder | den Hoed J , et al. (2018) | No | - |
25 | Support | Mutations in TBR1 gene leads to cortical malformations and intellectual disability | Vegas N , et al. (2018) | No | Autistic features |
26 | Recent Recommendation | Neonatal Tbr1 Dosage Controls Cortical Layer 6 Connectivity | Fazel Darbandi S , et al. (2018) | No | - |
27 | Support | Increased diagnostic and new genes identification outcome using research reanalysis of singleton exome sequencing | Bruel AL , et al. (2019) | No | ASD |
28 | Recent Recommendation | A TBR1-K228E Mutation Induces Tbr1 Upregulation, Altered Cortical Distribution of Interneurons, Increased Inhibitory Synaptic Transmission, and Autistic-Like Behavioral Deficits in Mice | Yook C , et al. (2019) | Yes | - |
29 | Support | Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism | Satterstrom FK et al. (2020) | Yes | - |
30 | Recent recommendation | De novo TBR1 variants cause a neurocognitive phenotype with ID and autistic traits: report of 25 new individuals and review of the literature | Nambot S , et al. (2020) | No | ASD or autistic features |
31 | Support | Excess of de novo variants in genes involved in chromatin remodelling in patients with marfanoid habitus and intellectual disability | Chevarin M et al. (2020) | No | Autistic features, marfanoid habitus |
32 | Support | A de novo frameshift pathogenic variant in TBR1 identified in autism without intellectual disability | Sapey-Triomphe LA et al. (2020) | Yes | - |
33 | Support | Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders | Wang T et al. (2020) | Yes | ID |
34 | Support | - | Hiraide T et al. (2021) | Yes | - |
35 | Support | - | Pode-Shakked B et al. (2021) | No | - |
36 | Support | - | Jin C et al. (2021) | No | - |
37 | Support | - | Chen S et al. (2021) | Yes | Epilepsy/seizures |
38 | Support | - | Crespo I et al. (2022) | No | - |
39 | Support | - | Zhang W et al. (2022) | Yes | - |
40 | Support | - | Zhou X et al. (2022) | Yes | - |
41 | Recent Recommendation | - | Sollis E et al. (2022) | Yes | DD, ID |
42 | Recent Recommendation | - | Weinschutz Mendes H et al. (2023) | Yes | - |
43 | Support | - | Sheth F et al. (2023) | Yes | DD, ID |
44 | Support | - | Tamam Khalaf et al. (2024) | No | - |
45 | Support | - | Siavash Fazel Darbandi et al. () | Yes | - |
46 | Support | - | Tsan-Ting Hsu et al. (2024) | Yes | - |
Rare Variants (68)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
- | - | copy_number_loss | De novo | - | - | 32005960 | Nambot S , et al. (2020) | |
- | - | copy_number_loss | De novo | - | - | 23112752 | Traylor RN , et al. (2012) | |
- | - | copy_number_loss | Unknown | - | - | 23112752 | Traylor RN , et al. (2012) | |
- | - | copy_number_loss | De novo | - | Simplex | 24458984 | Palumbo O , et al. (2014) | |
c.571C>T | p.Gln191Ter | stop_gained | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.896G>A | p.Trp299Ter | stop_gained | De novo | - | - | 31231135 | Bruel AL , et al. (2019) | |
c.471del | p.Tyr157Ter | stop_gained | Unknown | - | - | 32005960 | Nambot S , et al. (2020) | |
c.553C>T | p.Gln185Ter | stop_gained | De novo | - | - | 32005960 | Nambot S , et al. (2020) | |
c.844C>T | p.Gln282Ter | stop_gained | De novo | - | - | 32005960 | Nambot S , et al. (2020) | |
c.896G>A | p.Trp299Ter | stop_gained | De novo | - | - | 32005960 | Nambot S , et al. (2020) | |
c.280C>T | p.Arg94Cys | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.692G>A | p.Arg231Lys | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.1066G>A | p.Val356Met | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1174C>T | p.Arg392Trp | missense_variant | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.1252C>T | p.Gln418Ter | stop_gained | Unknown | - | Simplex | 33004838 | Wang T et al. (2020) | |
c.673A>T | p.Ile225Phe | missense_variant | De novo | - | - | 32005960 | Nambot S , et al. (2020) | |
c.811T>C | p.Trp271Arg | missense_variant | De novo | - | - | 32005960 | Nambot S , et al. (2020) | |
c.812G>C | p.Trp271Ser | missense_variant | De novo | - | - | 32005960 | Nambot S , et al. (2020) | |
c.1118A>G | p.Gln373Arg | missense_variant | De novo | - | - | 32005960 | Nambot S , et al. (2020) | |
c.1155C>G | p.Asn385Lys | missense_variant | De novo | - | - | 32005960 | Nambot S , et al. (2020) | |
c.896G>A | p.Trp299Ter | stop_gained | De novo | - | Simplex | 32277047 | Chevarin M et al. (2020) | |
c.1128+39C>G | - | intron_variant | De novo | - | Simplex | 31981491 | Satterstrom FK et al. (2020) | |
c.765T>A | p.Asp255Glu | missense_variant | Unknown | - | - | 28628100 | Geisheker MR , et al. (2017) | |
c.766G>T | p.Val256Leu | missense_variant | Unknown | - | - | 28628100 | Geisheker MR , et al. (2017) | |
c.932T>C | p.Leu311Pro | missense_variant | De novo | - | - | 29288087 | McDermott JH , et al. (2017) | |
c.689del | p.Gly230GlufsTer8 | frameshift_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.560del | p.Ala187ValfsTer29 | frameshift_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.946G>T | p.Gly316Ter | stop_gained | De novo | - | Simplex | 29288087 | McDermott JH , et al. (2017) | |
c.1175G>T | p.Arg392Leu | missense_variant | Familial | Paternal | - | 33004838 | Wang T et al. (2020) | |
c.1110del | p.Ala371ProfsTer10 | frameshift_variant | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.1157del | p.Pro386LeufsTer22 | frameshift_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.951_953del | p.Ser318del | inframe_deletion | Unknown | - | - | 38438125 | Tamam Khalaf et al. (2024) | |
c.1120A>C | p.Asn374His | missense_variant | De novo | - | Simplex | 22495311 | Neale BM , et al. (2012) | |
c.682A>G | p.Lys228Glu | missense_variant | De novo | - | Simplex | 23160955 | O'Roak BJ , et al. (2012) | |
c.811T>C | p.Trp271Arg | missense_variant | De novo | - | Simplex | 25356899 | Hamdan FF , et al. (2014) | |
c.1177dup | p.Asp393GlyfsTer2 | frameshift_variant | De novo | - | - | 32005960 | Nambot S , et al. (2020) | |
c.1165A>G | p.Lys389Glu | missense_variant | De novo | - | Simplex | 25418537 | O'Roak BJ , et al. (2014) | |
c.813G>T | p.Trp271Cys | missense_variant | De novo | - | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.1652dup | p.Gln552AlafsTer122 | frameshift_variant | De novo | - | - | 32005960 | Nambot S , et al. (2020) | |
c.1049dup | p.Ser351Ter | frameshift_variant | De novo | - | Simplex | 23160955 | O'Roak BJ , et al. (2012) | |
c.1120A>T | p.Asn374Tyr | missense_variant | De novo | - | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.1066G>A | p.Val356Met | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.813G>T | p.Trp271Cys | missense_variant | De novo | - | Simplex | 31981491 | Satterstrom FK et al. (2020) | |
c.284A>G | p.His95Arg | missense_variant | Familial | Paternal | Simplex | 37543562 | Sheth F et al. (2023) | |
c.1105_1113del | p.Val369_Ala371del | inframe_deletion | De novo | - | - | 32005960 | Nambot S , et al. (2020) | |
c.713_719del | p.Ser238ThrfsTer17 | frameshift_variant | De novo | - | - | 32005960 | Nambot S , et al. (2020) | |
c.1165A>G | p.Lys389Glu | missense_variant | De novo | - | Simplex | 31981491 | Satterstrom FK et al. (2020) | |
c.1132A>T | p.Thr378Ser | missense_variant | De novo | - | Simplex | 34580403 | Pode-Shakked B et al. (2021) | |
c.1660_c.1661insG | p.Cys554TrpfsTer120 | frameshift_variant | De novo | - | - | 34800434 | Chen S et al. (2021) | |
c.1588_1594dup | p.Thr532ArgfsTer144 | frameshift_variant | De novo | - | - | 31231135 | Bruel AL , et al. (2019) | |
c.1588_1594dup | p.Thr532ArgfsTer144 | frameshift_variant | De novo | - | - | 32005960 | Nambot S , et al. (2020) | |
c.1635_1644dup | p.Ser549GlyfsTer128 | frameshift_variant | De novo | - | - | 32005960 | Nambot S , et al. (2020) | |
c.1639_1648dup | p.Pro550ArgfsTer127 | frameshift_variant | De novo | - | - | 32005960 | Nambot S , et al. (2020) | |
c.1653_1654del | p.Gln552ValfsTer121 | frameshift_variant | De novo | - | - | 32005960 | Nambot S , et al. (2020) | |
c.401del | p.His134ProfsTer82 | frameshift_variant | De novo | - | Simplex | 22495309 | O'Roak BJ , et al. (2012) | |
c.91G>C | p.Glu31Gln | missense_variant | Familial | Paternal | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.1588_1594dup | p.Thr532ArgfsTer144 | frameshift_variant | De novo | - | - | 28554332 | Bowling KM , et al. (2017) | |
c.1635_1644dup | p.Ser549GlyfsTer128 | frameshift_variant | De novo | - | - | 27479843 | Lelieveld SH et al. (2016) | |
c.1369_1371delinsCA | p.Thr457GlnfsTer30 | frameshift_variant | De novo | - | - | 32005960 | Nambot S , et al. (2020) | |
c.933_934insCAAAGGA | p.Thr312GlnfsTer11 | frameshift_variant | De novo | - | - | 32005960 | Nambot S , et al. (2020) | |
c.443_444del | p.His148ProfsTer92 | frameshift_variant | De novo | - | Simplex | 33644862 | Hiraide T et al. (2021) | |
c.532C>G | p.Gln178Glu | missense_variant | Familial | Paternal | Simplex | 25232744 | Deriziotis P , et al. (2014) | |
c.1648_1657dup | p.Tyr553SerfsTer124 | frameshift_variant | De novo | - | Simplex | 35837997 | Zhang W et al. (2022) | |
c.1253A>G | p.Gln418Arg | missense_variant | Familial | Maternal | Simplex | 25232744 | Deriziotis P , et al. (2014) | |
c.1625C>G | p.Pro542Arg | missense_variant | Familial | Paternal | Simplex | 25232744 | Deriziotis P , et al. (2014) | |
c.26del | p.Pro9LeufsTer12 | frameshift_variant | De novo | - | Simplex | 32948248 | Sapey-Triomphe LA et al. (2020) | |
c.1588_1594dup | p.Thr532ArgfsTer144 | frameshift_variant | De novo | - | Simplex | 30268909 | Vegas N , et al. (2018) | |
c.370_374del | p.Phe124ValfsTer18 | frameshift_variant | Familial | Paternal | Simplex | 34794744 | Jin C et al. (2021) |
Common Variants (1)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Paternal Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
- | - | microsatellite | - | - | - | 28158988 | Bagshaw AT , et al. (2017) |
SFARI Gene score
High Confidence
Score Delta: Score remained at 1
criteria met
See SFARI Gene'scoring criteriaWe considered a rigorous statistical comparison between cases and controls, yielding genome-wide statistical significance, with independent replication, to be the strongest possible evidence for a gene. These criteria were relaxed slightly for category 2.
1/1/2021
Score remained at 1
Description
Two de novo LoF variants (one frameshift, one nonsense) and two de novo missense variants in TBR1 have been identified in simplex ASD cases (PMIDs 22495309, 23160955, 22495311); these variants were not observed in controls or in external databases. Functional analysis demonstrated that these four de novo TBR1 variants disrupt multiple aspects of TBR1 function, including interactions with co-regulators such as CASK and/or FOXP2, cellular localization, and transcriptional regulation (PMID 25232744). Microdeletions encompassing TBR1 have also been identified in patients with developmental delay/intellectual disability (PMIDs 23112752, 24458984). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified TBR1 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). den Hoed et al., 2018 functionally characterized two previously identified de novo TBR1 missense variants seen in ASD probands (p.Trp271Cys from De Rubeis et al., 2014 and p.Lys389Glu from ORoak et al., 2014) and determined that both variants disrupted multiple aspects of TBR1 function, including cellular localization and interactions with CASK, FOXP1, and FOXP2; the authors of this study also determined that the rare inherited TBR1 missense variant p.Gln418Arg (originally reported in an ASD proband in Deriziotis et al., 2014) disrupted the interaction between TBR1 and BCL11A.
10/1/2020
Score remained at 1
Description
Two de novo LoF variants (one frameshift, one nonsense) and two de novo missense variants in TBR1 have been identified in simplex ASD cases (PMIDs 22495309, 23160955, 22495311); these variants were not observed in controls or in external databases. Functional analysis demonstrated that these four de novo TBR1 variants disrupt multiple aspects of TBR1 function, including interactions with co-regulators such as CASK and/or FOXP2, cellular localization, and transcriptional regulation (PMID 25232744). Microdeletions encompassing TBR1 have also been identified in patients with developmental delay/intellectual disability (PMIDs 23112752, 24458984). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified TBR1 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). den Hoed et al., 2018 functionally characterized two previously identified de novo TBR1 missense variants seen in ASD probands (p.Trp271Cys from De Rubeis et al., 2014 and p.Lys389Glu from ORoak et al., 2014) and determined that both variants disrupted multiple aspects of TBR1 function, including cellular localization and interactions with CASK, FOXP1, and FOXP2; the authors of this study also determined that the rare inherited TBR1 missense variant p.Gln418Arg (originally reported in an ASD proband in Deriziotis et al., 2014) disrupted the interaction between TBR1 and BCL11A.
4/1/2020
Score remained at 1
Description
Two de novo LoF variants (one frameshift, one nonsense) and two de novo missense variants in TBR1 have been identified in simplex ASD cases (PMIDs 22495309, 23160955, 22495311); these variants were not observed in controls or in external databases. Functional analysis demonstrated that these four de novo TBR1 variants disrupt multiple aspects of TBR1 function, including interactions with co-regulators such as CASK and/or FOXP2, cellular localization, and transcriptional regulation (PMID 25232744). Microdeletions encompassing TBR1 have also been identified in patients with developmental delay/intellectual disability (PMIDs 23112752, 24458984). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified TBR1 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). den Hoed et al., 2018 functionally characterized two previously identified de novo TBR1 missense variants seen in ASD probands (p.Trp271Cys from De Rubeis et al., 2014 and p.Lys389Glu from ORoak et al., 2014) and determined that both variants disrupted multiple aspects of TBR1 function, including cellular localization and interactions with CASK, FOXP1, and FOXP2; the authors of this study also determined that the rare inherited TBR1 missense variant p.Gln418Arg (originally reported in an ASD proband in Deriziotis et al., 2014) disrupted the interaction between TBR1 and BCL11A.
1/1/2020
Score remained at 1
Description
Two de novo LoF variants (one frameshift, one nonsense) and two de novo missense variants in TBR1 have been identified in simplex ASD cases (PMIDs 22495309, 23160955, 22495311); these variants were not observed in controls or in external databases. Functional analysis demonstrated that these four de novo TBR1 variants disrupt multiple aspects of TBR1 function, including interactions with co-regulators such as CASK and/or FOXP2, cellular localization, and transcriptional regulation (PMID 25232744). Microdeletions encompassing TBR1 have also been identified in patients with developmental delay/intellectual disability (PMIDs 23112752, 24458984). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified TBR1 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). den Hoed et al., 2018 functionally characterized two previously identified de novo TBR1 missense variants seen in ASD probands (p.Trp271Cys from De Rubeis et al., 2014 and p.Lys389Glu from ORoak et al., 2014) and determined that both variants disrupted multiple aspects of TBR1 function, including cellular localization and interactions with CASK, FOXP1, and FOXP2; the authors of this study also determined that the rare inherited TBR1 missense variant p.Gln418Arg (originally reported in an ASD proband in Deriziotis et al., 2014) disrupted the interaction between TBR1 and BCL11A.
Reports Added
[Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci.2015] [Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism2020] [De novo TBR1 variants cause a neurocognitive phenotype with ID and autistic traits: report of 25 new individuals and review of the literature.2020]10/1/2019
Score remained at 1
New Scoring Scheme
Description
Two de novo LoF variants (one frameshift, one nonsense) and two de novo missense variants in TBR1 have been identified in simplex ASD cases (PMIDs 22495309, 23160955, 22495311); these variants were not observed in controls or in external databases. Functional analysis demonstrated that these four de novo TBR1 variants disrupt multiple aspects of TBR1 function, including interactions with co-regulators such as CASK and/or FOXP2, cellular localization, and transcriptional regulation (PMID 25232744). Microdeletions encompassing TBR1 have also been identified in patients with developmental delay/intellectual disability (PMIDs 23112752, 24458984). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified TBR1 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). den Hoed et al., 2018 functionally characterized two previously identified de novo TBR1 missense variants seen in ASD probands (p.Trp271Cys from De Rubeis et al., 2014 and p.Lys389Glu from ORoak et al., 2014) and determined that both variants disrupted multiple aspects of TBR1 function, including cellular localization and interactions with CASK, FOXP1, and FOXP2; the authors of this study also determined that the rare inherited TBR1 missense variant p.Gln418Arg (originally reported in an ASD proband in Deriziotis et al., 2014) disrupted the interaction between TBR1 and BCL11A.
7/1/2019
Score remained at 1
Description
Two de novo LoF variants (one frameshift, one nonsense) and two de novo missense variants in TBR1 have been identified in simplex ASD cases (PMIDs 22495309, 23160955, 22495311); these variants were not observed in controls or in external databases. Functional analysis demonstrated that these four de novo TBR1 variants disrupt multiple aspects of TBR1 function, including interactions with co-regulators such as CASK and/or FOXP2, cellular localization, and transcriptional regulation (PMID 25232744). Microdeletions encompassing TBR1 have also been identified in patients with developmental delay/intellectual disability (PMIDs 23112752, 24458984). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified TBR1 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). den Hoed et al., 2018 functionally characterized two previously identified de novo TBR1 missense variants seen in ASD probands (p.Trp271Cys from De Rubeis et al., 2014 and p.Lys389Glu from ORoak et al., 2014) and determined that both variants disrupted multiple aspects of TBR1 function, including cellular localization and interactions with CASK, FOXP1, and FOXP2; the authors of this study also determined that the rare inherited TBR1 missense variant p.Gln418Arg (originally reported in an ASD proband in Deriziotis et al., 2014) disrupted the interaction between TBR1 and BCL11A.
10/1/2018
Score remained at 1
Description
Two de novo LoF variants (one frameshift, one nonsense) and two de novo missense variants in TBR1 have been identified in simplex ASD cases (PMIDs 22495309, 23160955, 22495311); these variants were not observed in controls or in external databases. Functional analysis demonstrated that these four de novo TBR1 variants disrupt multiple aspects of TBR1 function, including interactions with co-regulators such as CASK and/or FOXP2, cellular localization, and transcriptional regulation (PMID 25232744). Microdeletions encompassing TBR1 have also been identified in patients with developmental delay/intellectual disability (PMIDs 23112752, 24458984). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified TBR1 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). den Hoed et al., 2018 functionally characterized two previously identified de novo TBR1 missense variants seen in ASD probands (p.Trp271Cys from De Rubeis et al., 2014 and p.Lys389Glu from ORoak et al., 2014) and determined that both variants disrupted multiple aspects of TBR1 function, including cellular localization and interactions with CASK, FOXP1, and FOXP2; the authors of this study also determined that the rare inherited TBR1 missense variant p.Gln418Arg (originally reported in an ASD proband in Deriziotis et al., 2014) disrupted the interaction between TBR1 and BCL11A.
Reports Added
[Recurrent de novo mutations implicate novel genes underlying simplex autism risk.2014] [Functional characterization of TBR1 variants in neurodevelopmental disorder.2018] [Mutations in TBR1 gene leads to cortical malformations and intellectual disability.2018] [Neonatal Tbr1 Dosage Controls Cortical Layer 6 Connectivity.2018]7/1/2017
Score remained at 1
Description
Two de novo LoF variants (one frameshift, one nonsense) and two de novo missense variants in TBR1 have been identified in simplex ASD cases (PMIDs 22495309, 23160955, 22495311); these variants were not observed in controls or in external databases. Functional analysis demonstrated that these four de novo TBR1 variants disrupt multiple aspects of TBR1 function, including interactions with co-regulators such as CASK and/or FOXP2, cellular localization, and transcriptional regulation (PMID 25232744). Microdeletions encompassing TBR1 have also been identified in patients with developmental delay/intellectual disability (PMIDs 23112752, 24458984). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified TBR1 as a gene meeting high statistical significance with a FDR ? 0.01, meaning that this gene had a ? 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
4/1/2017
Score remained at 1
Description
Two de novo LoF variants (one frameshift, one nonsense) and two de novo missense variants in TBR1 have been identified in simplex ASD cases (PMIDs 22495309, 23160955, 22495311); these variants were not observed in controls or in external databases. Functional analysis demonstrated that these four de novo TBR1 variants disrupt multiple aspects of TBR1 function, including interactions with co-regulators such as CASK and/or FOXP2, cellular localization, and transcriptional regulation (PMID 25232744). Microdeletions encompassing TBR1 have also been identified in patients with developmental delay/intellectual disability (PMIDs 23112752, 24458984). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified TBR1 as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
Reports Added
[Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.2012] [Patterns and rates of exonic de novo mutations in autism spectrum disorders.2012] [Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.2012] [Synaptic, transcriptional and chromatin genes disrupted in autism.2014] [Investigation of TBR1 Hemizygosity: Four Individuals with 2q24 Microdeletions.2012] [TBR1 is the candidate gene for intellectual disability in patients with a 2q24.2 interstitial deletion.2014] [Tbr1 haploinsufficiency impairs amygdalar axonal projections and results in cognitive abnormality.2014] [De novo TBR1 mutations in sporadic autism disrupt protein functions.2014] [Neuronal excitation upregulates Tbr1, a high-confidence risk gene of autism, mediating Grin2b expression in the adult brain.2014] [T-Brain-1 - A Potential Master Regulator in Autism Spectrum Disorders.2015] [Low load for disruptive mutations in autism genes and their biased transmission.2015] [TBR1 regulates autism risk genes in the developing neocortex.2016] [Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability2016] [Microsatellite polymorphisms associated with human behavioural and psychological phenotypes including a gene-environment interaction.2017] [Nuclear translocation and transcription regulation by the membrane-associated guanylate kinase CASK/LIN-2.2000] [Calcium/calmodulin-dependent serine protein kinase (CASK), a protein implicated in mental retardation and autism-spectrum disorders, interacts with...2017] [De novo mutations in moderate or severe intellectual disability.2014] [Genomic diagnosis for children with intellectual disability and/or developmental delay.2017]1/1/2017
Score remained at 1
Description
Two de novo LoF variants (one frameshift, one nonsense) and two de novo missense variants in TBR1 have been identified in simplex ASD cases (PMIDs 22495309, 23160955, 22495311); these variants were not observed in controls or in external databases. Functional analysis demonstrated that these four de novo TBR1 variants disrupt multiple aspects of TBR1 function, including interactions with co-regulators such as CASK and/or FOXP2, cellular localization, and transcriptional regulation (PMID 25232744). Microdeletions encompassing TBR1 have also been identified in patients with developmental delay/intellectual disability (PMIDs 23112752, 24458984). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified TBR1 as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
Reports Added
[Microsatellite polymorphisms associated with human behavioural and psychological phenotypes including a gene-environment interaction.2017] [Nuclear translocation and transcription regulation by the membrane-associated guanylate kinase CASK/LIN-2.2000] [Calcium/calmodulin-dependent serine protein kinase (CASK), a protein implicated in mental retardation and autism-spectrum disorders, interacts with...2017]7/1/2016
Score remained at 1
Description
Two de novo LoF variants (one frameshift, one nonsense) and two de novo missense variants in TBR1 have been identified in simplex ASD cases (PMIDs 22495309, 23160955, 22495311); these variants were not observed in controls or in external databases. Functional analysis demonstrated that these four de novo TBR1 variants disrupt multiple aspects of TBR1 function, including interactions with co-regulators such as CASK and/or FOXP2, cellular localization, and transcriptional regulation (PMID 25232744). Microdeletions encompassing TBR1 have also been identified in patients with developmental delay/intellectual disability (PMIDs 23112752, 24458984). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified TBR1 as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
1/1/2016
Score remained at 1
Description
Two de novo LoF variants (one frameshift, one nonsense) and two de novo missense variants in TBR1 have been identified in simplex ASD cases (PMIDs 22495309, 23160955, 22495311); these variants were not observed in controls or in external databases. Functional analysis demonstrated that these four de novo TBR1 variants disrupt multiple aspects of TBR1 function, including interactions with co-regulators such as CASK and/or FOXP2, cellular localization, and transcriptional regulation (PMID 25232744). Microdeletions encompassing TBR1 have also been identified in patients with developmental delay/intellectual disability (PMIDs 23112752, 24458984). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified TBR1 as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
Reports Added
[Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.2012] [Patterns and rates of exonic de novo mutations in autism spectrum disorders.2012] [Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.2012] [Synaptic, transcriptional and chromatin genes disrupted in autism.2014] [Investigation of TBR1 Hemizygosity: Four Individuals with 2q24 Microdeletions.2012] [TBR1 is the candidate gene for intellectual disability in patients with a 2q24.2 interstitial deletion.2014] [Tbr1 haploinsufficiency impairs amygdalar axonal projections and results in cognitive abnormality.2014] [De novo TBR1 mutations in sporadic autism disrupt protein functions.2014] [Neuronal excitation upregulates Tbr1, a high-confidence risk gene of autism, mediating Grin2b expression in the adult brain.2014] [T-Brain-1 - A Potential Master Regulator in Autism Spectrum Disorders.2015] [Low load for disruptive mutations in autism genes and their biased transmission.2015]1/1/2015
Score remained at 1
Description
Two de novo LGD variants (one frameshift, one nonsense) and two de novo missense variants in TBR1 have been identified in simplex ASD cases (PMIDs 22495309, 23160955, 22495311); these variants were not observed in controls or in external databases. Functional analysis demonstrated that these four de novo TBR1 variants disrupt multiple aspects of TBR1 function, including interactions with co-regulators such as CASK and/or FOXP2, cellular localization, and transcriptional regulation (PMID 25232744). Microdeletions encompassing TBR1 have also been identified in patients with developmental delay/intellectual disability (PMIDs 23112752, 24458984). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified TBR1 as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760).
10/1/2014
Decreased from 2 to 1
Description
Two de novo LGD variants (one frameshift, one nonsense) and two de novo missense variants in TBR1 have been identified in simplex ASD cases (PMIDs 22495309, 23160955, 22495311); these variants were not observed in controls or in external databases. Functional analysis demonstrated that these four de novo TBR1 variants disrupt multiple aspects of TBR1 function, including interactions with co-regulators such as CASK and/or FOXP2, cellular localization, and transcriptional regulation (PMID 25232744). Microdeletions encompassing TBR1 have also been identified in patients with developmental delay/intellectual disability (PMIDs 23112752, 24458984). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified TBR1 as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760).
Reports Added
[Patterns and rates of exonic de novo mutations in autism spectrum disorders.2012] [De novo TBR1 mutations in sporadic autism disrupt protein functions.2014] [Neuronal excitation upregulates Tbr1, a high-confidence risk gene of autism, mediating Grin2b expression in the adult brain.2014] [Synaptic, transcriptional and chromatin genes disrupted in autism.2014]7/1/2014
Increased from No data to 2
Description
Two de novo LGD variants (one frameshift, one nonsense) and two de novo missense variants in TBR1 have been identified in simplex ASD cases (PMIDs 22495309, 23160955, 22495311); these variants were not observed in controls or in external databases. Functional analysis demonstrated that these four de novo TBR1 variants disrupt multiple aspects of TBR1 function, including interactions with co-regulators such as CASK and/or FOXP2, cellular localization, and transcriptional regulation (PMID 25232744). Microdeletions encompassing TBR1 have also been identified in patients with developmental delay/intellectual disability (PMIDs 23112752, 24458984).
4/1/2014
Increased from No data to 3
Description
In a screen of 44 genes in 2,446 ASD probands, PMID 23160955 reported 2 de novo LGD in TBR1
Krishnan Probability Score
Score 0.61171905614202
Ranking 193/25841 scored genes
[Show Scoring Methodology]
ExAC Score
Score 0.99358803746459
Ranking 1629/18225 scored genes
[Show Scoring Methodology]
Iossifov Probability Score
Score 0.976
Ranking 47/239 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.00015371128216179
Ranking 14/18665 scored genes
[Show Scoring Methodology]
Larsen Cumulative Evidence Score
Score 78
Ranking 15/461 scored genes
[Show Scoring Methodology]
Zhang D Score
Score 0.43844562288918
Ranking 1046/20870 scored genes
[Show Scoring Methodology]
External PIN Data
Interactome
- Protein Binding
- DNA Binding
- RNA Binding
- Protein Modification
- Direct Regulation
- ASD-Linked Genes
Interaction Table
Interactor Symbol | Interactor Name | Interactor Organism | Interactor Type | Entrez ID | Uniprot ID |
---|---|---|---|---|---|
Cd200 | CD200 antigen | Mouse | Direct Regulation | 17470 | O54901 |
Il7r | interleukin 7 receptor | Mouse | Direct Regulation | 16197 | P16872 |